Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
freegriff's Profile
Displaying 1-50 of 1548 result(s).
AMBS Amarantus Bioscience Holdings
05/06/2025 8:07:22 PM
TylerDurden Now that's a name I've
AMBS Amarantus Bioscience Holdings
05/04/2025 8:37:32 PM
New Chinese MANF research in Retini (1)
AMBS Amarantus Bioscience Holdings
05/02/2025 10:33:40 PM
29900% lol gtfoh
AMBS Amarantus Bioscience Holdings
04/23/2025 2:57:54 PM
To the market makers, speculators, (2)
AMBS Amarantus Bioscience Holdings
04/23/2025 2:56:16 PM
No other stockholders get +9900% da (1)
AMBS Amarantus Bioscience Holdings
04/14/2025 12:13:55 PM
New MANF research in Nature for Pne (3)
AMBS Amarantus Bioscience Holdings
04/07/2025 11:49:08 PM
New MANF therapy for Peripheral Ner (4)
AMBS Amarantus Bioscience Holdings
03/08/2025 11:19:51 PM
New MANF research in diabetes and m (5)
AMBS Amarantus Bioscience Holdings
03/01/2025 11:16:50 AM
Latest newsletter from Snow Foundat (2)
AMBS Amarantus Bioscience Holdings
02/24/2025 8:55:17 AM
Love that he's chatting but makes m (2)
AMBS Amarantus Bioscience Holdings
02/22/2025 11:35:37 PM
5 count em 5! New MANF research art (3)
AMBS Amarantus Bioscience Holdings
02/22/2025 11:13:16 PM
Dr. Urano will be on the steering C (1)
AMBS Amarantus Bioscience Holdings
02/21/2025 5:36:06 PM
6.63M volume day. Is this for real? (1)
AMBS Amarantus Bioscience Holdings
02/20/2025 9:41:53 AM
New from Nature: MANF and a form of (2)
AMBS Amarantus Bioscience Holdings
02/09/2025 11:17:28 AM
Big for us. Reduces risk. First bra (2)
AMBS Amarantus Bioscience Holdings
01/27/2025 5:33:22 AM
Nature has a new AI guided research (2)
AMBS Amarantus Bioscience Holdings
01/07/2025 10:28:34 AM
MANF and PFAS (the forever chemical (3)
AMBS Amarantus Bioscience Holdings
12/20/2024 10:12:43 AM
First news article on MANF I've see (3)
AMBS Amarantus Bioscience Holdings
12/10/2024 6:53:44 PM
New MANF research in Sepsis-associa (3)
AMBS Amarantus Bioscience Holdings
11/27/2024 4:27:00 PM
Happy Thanksgiving everyone! (2)
AMBS Amarantus Bioscience Holdings
11/22/2024 9:57:28 PM
2x new MANF articles, big summary u (2)
AMBS Amarantus Bioscience Holdings
11/15/2024 11:08:25 AM
2x forthcoming MANF in Kidney Disea (3)
AMBS Amarantus Bioscience Holdings
11/08/2024 11:29:50 AM
Big new research out of NYC on reco (3)
AMBS Amarantus Bioscience Holdings
10/21/2024 5:06:08 PM
Two new MANF research articles in A (3)
AMBS Amarantus Bioscience Holdings
10/14/2024 11:52:38 PM
Dr. Urano October Update October 14 (3)
AMBS Amarantus Bioscience Holdings
10/05/2024 8:01:07 PM
New: MANF in Liver Regeneration MAN (3)
AMBS Amarantus Bioscience Holdings
09/17/2024 8:26:29 PM
Gerald is still tending. It's winte (2)
AMBS Amarantus Bioscience Holdings
09/01/2024 12:38:38 PM
Dr. Urano Autumn update: "Regenerat (3)
AMBS Amarantus Bioscience Holdings
07/16/2024 1:19:35 PM
Z trades? Interesting to see these
AMBS Amarantus Bioscience Holdings
07/11/2024 11:56:37 AM
New MANF Research on Spinal and bul (3)
AMBS Amarantus Bioscience Holdings
06/05/2024 3:42:23 AM
3x MANF research articles: Cervical (3)
AMBS Amarantus Bioscience Holdings
05/25/2024 8:36:05 AM
New MANF Research in Liver Cancer R (2)
AMBS Amarantus Bioscience Holdings
05/09/2024 8:02:35 AM
2x new MANF articles 1) Mesencephal (2)
AMBS Amarantus Bioscience Holdings
05/01/2024 6:08:23 PM
Judgement against Magna is out. In (2)
AMBS Amarantus Bioscience Holdings
04/02/2024 9:45:37 AM
You need a Pacer account. There is
AMBS Amarantus Bioscience Holdings
03/29/2024 8:59:33 PM
Magna Update: issues were resolved (5)
AMBS Amarantus Bioscience Holdings
03/05/2024 6:51:19 AM
Emerald Biotherapeutics is a Delawa (3)
AMBS Amarantus Bioscience Holdings
03/05/2024 6:33:24 AM
Funi Urano Wolframs presentation at (2)
AMBS Amarantus Bioscience Holdings
03/02/2024 5:29:12 AM
Next update March 29. Negotiating s (3)
AMBS Amarantus Bioscience Holdings
02/18/2024 3:06:36 AM
Friggin lawyers man (1)
AMBS Amarantus Bioscience Holdings
02/17/2024 3:35:33 AM
Next update March 1 February 16, 20 (2)
AMBS Amarantus Bioscience Holdings
02/06/2024 6:22:19 PM
Yes Yes Maybe No (1)
AMBS Amarantus Bioscience Holdings
02/04/2024 11:21:24 PM
Gerald no longer CEO of Todos as of
AMBS Amarantus Bioscience Holdings
01/25/2024 3:29:41 AM
Another new MANF paper from the Fin (3)
AMBS Amarantus Bioscience Holdings
01/18/2024 6:10:32 AM
Unfortunately, because the financia (2)
AMBS Amarantus Bioscience Holdings
01/18/2024 6:05:19 AM
Amarantus owns 100% of MANF Therape (2)
AMBS Amarantus Bioscience Holdings
01/11/2024 8:19:55 PM
Dr. Urano has been invited to speak (3)
AMBS Amarantus Bioscience Holdings
01/10/2024 8:09:15 PM
Another new MANF study: Neurotrophi (3)
AMBS Amarantus Bioscience Holdings
01/07/2024 12:11:10 AM
2024: the year of MANF End of year (3)
AMBS Amarantus Bioscience Holdings
01/05/2024 9:27:17 PM
Magna Update - looks like settlemen (3)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Management Board Restructuring at Enefit Green Group
  • Strengthening Ties: Xi and Putin Forge a New Era
  • Insight into Man Group's Position on LondonMetric Property
  • Man Group PLC Updates on Disclosure Regarding Dalata Hotel Group
  • Delta and Korean Air Invest in WestJet for Enhanced Travel
  • FinVolution Group Announces Upcoming Financial Results Call
  • Exciting Announcement: Yatsen's Upcoming Financial Results
  • Pylontech Launches Innovative Energy Solutions for Businesses
  • Building Bridges for Deaf Youth: Vantage Foundation's Mission
  • Vantage Foundation Collaborates to Transform Deaf Education
  • Frontera Energy Highlights Strong Q1 2025 Financial Performance
  • International Students Celebrate Chinese Culture with Videos
  • GCL SI Highlights Innovations and Solutions for Solar Energy
  • Investec Bank's Engagement with Dowlais Group: Ownership Insights
  • FLEX LNG Announces Key Outcomes from Recent AGM Meeting
  • Valmet's Capital Markets Day: A Comprehensive Overview
  • IASO Bio's Breakthrough in Cancer Treatment Gains Recognition
  • Fluence Energy Faces Class Action Over Substantial Investor Losses
  • Pylontech Introduces Cutting-Edge Energy Storage Solutions
  • Insights into De La Rue's Public Trading Disclosure Process
  • Key Insights from FD Technologies' Public Dealing Disclosure
  • Exploring India's Promising Fintech Landscape: Future Growth Ahead
  • Understanding Exempt Principal Trader Rules for Anexo Group
  • Latest Insights on Riksbank Bond Auctions and Market Dynamics
  • Thruvision Group's Recent Disclosure Signals Strategic Movement
  • Sungrow Unveils Innovative C&I Solutions to Transform Business
  • GIGABYTE Showcases Cutting-Edge AI Innovations at Major Event
  • Unlock Rewards with Bybit P2P Block Trading Opportunities
  • ISS Expands Facility Services Partnership in APAC Region
  • Innovative Microdisplay Technology by Himax Set to Transform AR
  • Discover the Beijing Central Axis at Expo 2025 Osaka's Showcase
  • Octopus AIM VCT plc Reports Updated Net Asset Value
  • Understanding Net Asset Value for Octopus AIM VCT 2 plc
  • CRRC Zhuzhou Institute Introduces Innovative Clean Energy Solutions
  • APMH Invest Secures Regulatory Approval for Svitzer Shares Acquisition
  • ASE Technology Shares Monthly Revenue Updates and Insights
  • Ambitious Plans for Renewable Energy Supply in India
  • Exciting Innovations at TOKEN2049 with BloFin's Growth Surge
  • Recent Share Transactions by Danske Bank Leaders Highlight Growth
  • Implantica Reports Growth and Innovations in First Quarter
  • RaySearch Laboratories Reports Strong First Quarter Results
  • Ulrika Kolsrud to Lead Essity as New President and CEO
  • Ulrika Kolsrud Takes Leadership Role at Essity
  • Water-based Heating & Cooling Systems Market to Reach $73.53 Billion
  • Exploring the Growth of the Periodontal Therapeutics Market
  • Bekaert Executes Share Buyback and ReportsLiquidity Actions
  • OSB Group PLC Takes Big Steps with Own Shares Transaction
  • Strategic Share Buyback Announcement by NB Private Equity Partners
  • Foresight Group Holdings Limited Reports Share Buyback Activity
  • Middlefield Canadian Income PCC Reports Important Shareholder Activity
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site